Skip to main content

Advertisement

SpringerLink
Log in

Transconjunctival immunotherapy using cholera toxin B to treat experimental allergic conjunctivitis in a mouse model

  • Laboratory Investigation
  • Published:
Japanese Journal of Ophthalmology Aims and scope Submit manuscript

Abstract

Purpose

We evaluated the use of immunological biomarkers in transconjunctival immunotherapy by using cholera toxin B for treating experimental allergic conjunctivitis in a mouse model.

Methods

Balb/c mice were sensitized using intraperitoneal injections of ovalbumin (OVA) and were then divided into two groups. The first group was treated by topical instillation of OVA after the instillation of combined OVA and cholera toxin B (CTB) solution B group). The second group was treated by topical instillation of OVA alone (allergy group). The control group consisted of nonsensitized mice undergoing topical OVA instillation only. The numbers of eosinophils and CD4-positive lymphocytes in the conjunctiva were determined histologically, and the observation of immunoglobulin A (IgA)-positive cells in the conjunctiva was performed by immunohistochemistry. Cytokine concentration in the conjunctiva was determined by the protein-array methods. Messenger RNA expression of T-cell-specific markers, such as T-bet, GATA-3, and Foxp3, in the conjunctiva was detected by reversed transcriptase polymerase chain reaction.

Results

The number of eosinophils and CD4-positive lymphocytes increased significantly in the allergy group compared with the control group (P < 0.001) but showed no difference between the CTB group and control group. Concentrations of interleukin 4 (IL-4) (P < 0.05), B-lymphocyte chemoattractant (P < 0.01), and thymus-expressed chemokine (P < 0.05) in the conjunctiva were significantly higher in the CTB group than in the other two groups. GATA-3 messenger RNA (mRNA) in the conjunctiva was expressed in the three groups, but T-bet and Foxp3 were not detected.

Conclusion

Transconjunctival immunotherapy using CTB can be evaluated by histological examination of eosinophils and CD4-positive T cells, and a mucosal immunity-associated chemokine and a helper T-cell-17-associated chemokine as biomarkers.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  1. Rolland JM, Gardner LM, O’Hehir RE, et al. Allergen-related approaches to immunotherapy. Pharmacol Ther. 2009;121:273–84.

    Article  CAS  PubMed  Google Scholar 

  2. Saito K, Shoji J, Inada N, Iwasaki Y, Sawa M, et al. Immunosupressive effect of cholera toxin B on allergic conjunctivitis model in guinea pig. Jpn J Ophthalmol. 2001;45:332–8.

    Article  CAS  PubMed  Google Scholar 

  3. Shoji J, Sakimoto T, Muromoto K, Inada N, Sawa M, Ra C, et al. Comparison of topical dexamethasone and topical FK506 treatment for the experimental allergic conjunctivitis model in Balb/c mice. Jpn J Ophthalmol. 2005;49:205–10.

    Article  CAS  PubMed  Google Scholar 

  4. Cohen SG, Frankland AW, Dworetzky M. Noon and Freeman on prophylactic inoculation against hay fever. J Allergy Clin Immunol. 2003;111:1572.

    Article  Google Scholar 

  5. Li G, Liu Z, Zhong N, Liao B, Xiong Y, et al. Therapeutic effects of DNA vaccine on allergen-induced allergic airway inflammation in mouse model. Cell Mol Immunol. 2006;3:379–84.

    CAS  PubMed  Google Scholar 

  6. Koizumi T, Abe T. Induction of oral tolerance to experimental allergic conjunctivitis in rats. Nippon Ganka Gakkai Zasshi. 1995;99:515–20.

    CAS  PubMed  Google Scholar 

  7. Nunez JA, Cuesta U, et al. Local conjunctival immunotherapy: the effect of dermatophagoides pteronyssinus local conjunctival immunotherapy on conjunctival provocation test in patients with allergic conjunctivitis. Allergol et Immunopathol. 2000;28:301–6.

    CAS  Google Scholar 

  8. Ventura MT, Carretta A, Tummolo RA, Buquicchio R, Arsieni A, Murgia N, et al. Clinical data and inflammation parameters in patients with cypress allergy treated with sublingual swallow therapy and subcutaneous immunotherapy. Int J Immunopathol Pharmacol. 2009;22:403–13.

    Article  CAS  PubMed  Google Scholar 

  9. Rask C, Holmgren J, Fredriksson M, Lindblad M, Nordström I, Sun JB, et al. Prolonged oral treatment with low doses of allergen conjugated to cholera toxin B subunit suppresses immunoglobulin E antibody responses in sensitized mice. Clin Exp Allergy. 2000;30:1024–32.

    Article  CAS  PubMed  Google Scholar 

  10. Sun JB, Cuburu N, Blomquist M, Li BL, Czerkinsky C, Holmgren J, et al. Sublingual tolerance induction with antigen conjugated to cholera toxin B subunit induces Foxp3+ CD25+ CD4+ regulatory T cells and suppresses delayed-type hypersensitivity reactions. Scand J Immunol. 2006;64:251–9.

    Article  CAS  PubMed  Google Scholar 

  11. Shoji J, Kitazawa M, Inada N, Sawa M, Ono T, Kawamura M, et al. Efficacy of tear eosinophil cationic protein level measurement using filter paper for diagnosing allergic conjunctival disorders. Jpn J Ophthalmol. 2003;47:64–8.

    Article  CAS  PubMed  Google Scholar 

  12. Wurbel MA, Philippe JM, Nguyen C, Victorero G, Freeman T, Wooding P, et al. The chemokine TECK is expressed by thymic and intestinal epithelial cells and attracts double- and single-positive thymocytes expressing the TECK receptor CCR9. Eur J Immunol. 2000;30:262–71.

    Article  CAS  PubMed  Google Scholar 

  13. Zabel BA, Agace WW, Campbell JJ, Heath HM, Parent D, Roberts AI, et al. Human G protein-coupled receptor GPR-9-6/CC chemokine receptor 9 is selectively expressed on intestinal homing T lymphocytes, mucosal lymphocytes, and thymocytes, and is required for thymus-expressed chemokine-mediated chemotaxis. J Exp Med. 1999;190:1241–56.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Hosoe N, Miura S, Watanabe C, Tsuzuki Y, Hokari R, Oyama T, et al. Demonstration of functional role of TECK/CCL25 in T lymphocyte-endothelium interaction in inflamed and uninflamed intestinal mucosa. Am J Physiol Gastrointest Liver Physiol. 2004;286:G458–66.

    Article  CAS  PubMed  Google Scholar 

  15. Takagi R, Higashi T, Hashimoto K, Nakano K, Mizuno Y, Okazaki Y. B cell chemoattractant CXCL13 is preferentially expressed by human Th17 cell clones. J Immunol. 2008;18:186–9.

    Article  Google Scholar 

  16. Knop N, Knop E, et al. Conjunctiva-associated lymphoid tissue in the human eye. Invest Ophthalmol Vis Sci. 2000;41:1270–9.

    CAS  PubMed  Google Scholar 

  17. Inada N, Shoji J, Takaura N, Sawa M, et al. A morphological study of lymphocyte homing in conjunctiva-associated lymphoid tissue. Nippon Ganka Gakkai Zasshi. 1995;99:1111–8.

    CAS  PubMed  Google Scholar 

  18. Sakimoto T, Shoji J, Inada N, Saito K, Iwasaki Y, Sawa M, et al. Histological study of conjunctiva-associated lymphoid tissue in mouse. Jpn J Ophthalmol. 2002;46:364–9.

    Article  CAS  PubMed  Google Scholar 

  19. Kim HJ, Kim JK, Seo SB, Lee HJ, Kim HJ, et al. Intranasal vaccination with peptides and cholera toxin subunit B as adjuvant to enhance mucosal and systemic immunity to respiratory syncytial virus. Arch Pharm Res. 2007;30:366–71.

    Article  CAS  PubMed  Google Scholar 

  20. Wang M, Bregenholt S, Petersen JS, et al. The cholera toxin B subunit directly costimulates antigen-primed CD4+ T cells ex vivo. Scand J Immunol. 2003;58:342–9.

    Article  CAS  PubMed  Google Scholar 

  21. Inada N, Shoji J, Hoshino M, Sawa M, et al. Evaluation of total and allergen-specific secretory IgA in tears in allergic conjunctival disease. Jpn J Ophthalmol. 2007;51:338–42.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

We thank Ms. Akiko Ishimori, Department of Ophthalmology, Nihon University School of Medicine, for her expert technical assistance

Author information

Authors and Affiliations

  1. Division of Visual Sciences, Department of Ophthalmology, Nihon University School of Medicine, 30-1 Oyaguchi-Kamimachi, Itabashi-ku, Tokyo, 173-8610, Japan

    Aki Oikawa, Jun Shoji, Noriko Inada & Mitsuru Sawa

Authors
  1. Aki Oikawa
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jun Shoji
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Noriko Inada
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Mitsuru Sawa
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Aki Oikawa.

About this article

Cite this article

Oikawa, A., Shoji, J., Inada, N. et al. Transconjunctival immunotherapy using cholera toxin B to treat experimental allergic conjunctivitis in a mouse model. Jpn J Ophthalmol 55, 534–540 (2011). https://doi.org/10.1007/s10384-011-0047-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10384-011-0047-x

Keywords

Search

Navigation